Neogen (NEOG) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 16.82% |
| Nov 30, 2025 | 5.00% |
| Aug 31, 2025 | 17.91% |
| May 31, 2025 | 14.25% |
| Feb 28, 2025 | 20.26% |
| Nov 30, 2024 | 16.12% |
| Aug 31, 2024 | 16.44% |
| May 31, 2024 | 32.56% |
| Feb 29, 2024 | 11.52% |
| Nov 30, 2023 | 15.16% |
| Aug 31, 2023 | 12.96% |
| May 31, 2023 | 14.46% |
| Feb 28, 2023 | -3.94% |
| Nov 30, 2022 | 9.19% |
| Aug 31, 2022 | 12.87% |
| May 31, 2022 | -10.53% |
| Feb 28, 2022 | -6.46% |
| Nov 30, 2021 | -9.94% |
| Aug 31, 2021 | -1.32% |
| May 31, 2021 | 6.47% |
| Feb 28, 2021 | 1.91% |
| Nov 30, 2020 | 9.79% |
| Aug 31, 2020 | 7.56% |
| May 31, 2020 | 0.06% |
| Feb 29, 2020 | -2.45% |
| Nov 30, 2019 | 6.25% |
| Aug 31, 2019 | 1.04% |
| May 31, 2019 | 0.49% |
| Feb 28, 2019 | 16.68% |
| Nov 30, 2018 | 18.42% |
| Aug 31, 2018 | 17.39% |
| May 31, 2018 | 10.67% |
| Feb 28, 2018 | 10.93% |
| Nov 30, 2017 | 9.30% |
| Aug 31, 2017 | 5.61% |
| May 31, 2017 | 9.60% |
| Feb 28, 2017 | 7.00% |
| Nov 30, 2016 | 18.47% |
| Aug 31, 2016 | 28.16% |
| May 31, 2016 | 9.04% |
| Feb 29, 2016 | 17.24% |
| Nov 30, 2015 | 21.39% |
| Aug 31, 2015 | 13.21% |
| May 31, 2015 | 23.70% |